Emergent BioSolutions (EBS) Short term Debt (2010 - 2020)

Emergent BioSolutions' Short term Debt history runs 7 years deep, the most recent figure standing at $22.3 million for Q2 2020.

• In Q2 2020, Short term Debt fell 59.16% year-over-year to $22.3 million; the TTM figure through Jun 2020 stood at $22.3 million (down 59.16% YoY), while the FY2019 annual figure was $3.2 million, down 68.32% from the prior year.
• Short term Debt was $22.3 million for Q2 2020 at Emergent BioSolutions, up from $3.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $62.7 million in Q1 2019 to a low of $3.2 million in Q4 2019.
• Historically, Short term Debt has averaged $27.2 million across 3 years, with a median of $16.2 million in 2018.
• The sharpest annual moves came in 2019 and 2020: Short term Debt tumbled 68.32% in 2019, then slumped 59.16% in 2020.
• A 3-year view of Short term Debt shows it stood at $10.1 million in 2018, then sank by 68.32% to $3.2 million in 2019, then soared by 596.88% to $22.3 million in 2020.
• The last three Short term Debt figures came in at $22.3 million (Q2 2020), $3.2 million (Q4 2019), and $10.1 million (Q3 2019), per Business Quant data.